Bone Graft for Revision Hip Arthroplasty: Biology and Future Applications

Clinical Orthopaedics and Related Research

Volumn 417, Issue , 2003, Pages 183-194

  Gamradt, Seth C ^a   Lieberman, Jay R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL; CALCIUM PHOSPHATE; CALCIUM SULFATE; CYTOKINE; GROWTH FACTOR; LIM PROTEIN; OSTEOGENIC PROTEIN 1; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT PROTEIN; THROMBOCYTE CONCENTRATE;

ACETABULUM; ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AUTOGRAFT; BONE CONDUCTION; BONE DEFECT; BONE GRAFT; BONE MATRIX; BONE REMODELING; CANCELLOUS BONE; CERAMICS; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICAL BONE; DISEASE ASSOCIATION; ENDOPROSTHESIS LOOSENING; FEMUR HEAD; FEMUR SHAFT; GENE THERAPY; HEMATOPOIETIC STEM CELL; HIP ARTHROPLASTY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; ILIAC CREST; IMAGE ANALYSIS; IMAGING; INFECTION RISK; MORBIDITY; NONHUMAN; OSTEOLYSIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RADIOGRAPHY; RAT; REOPERATION; STEM CELL; SURGICAL TECHNIQUE; TISSUE ENGINEERING; TREATMENT INDICATION; VIRUS TRANSMISSION;

EID: 0345060425     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (87)

1. Ahlmann E, Patzakis M, Roidis N, Shepherd L, Holtom P: Comparison of anterior and posterior iliac crest bone grafts in terms of harvest-site morbidity and functional outcomes. J Bone Joint Surg 84A:716-720, 2002.
2. Avci S, Connors N, Petty W: 2- to 10-year follow-up study of acetabular revisions using allograft bone to repair bone defects. J Arthroplasty 13: 61-69, 1998.
3. Bauer TW, Smith ST: Bioactive materials in orthopaedic surgery: Overview and regulatory considerations. Clin Orthop 395;11-22, 2002.
4. Berven S, Tay BK, Kleinstueck FS, Bradford DS: Clinical applications of bone graft substitutes in spine surgery: Consideration of mineralized and demineralized preparations and growth factor supplementation. Eur Spine J 10(Suppl 2):169-177, 2001.
5. Blaha JD: Calcium sulfate bone-void filler. Orthopedics 21:1017-1019, 1998.
6. Boden SD, Martin Jr GJ, Horton WC, Truss TL, Sandhu HS: Laparoscopic anterior spinal arthrodesis with rhBMP-2 in a titanium interbody threaded cage. J Spinal Disord 11:95-101, 1998.
7. Boden SD, Titus L, Hair G, et al: Lumbar spine fusion by local gene therapy with a cDNA encoding a novel osteoinductive protein (LMP-1). Spine 23:2486-2492, 1998.
8. Bos GD, Goldberg VM, Zika J, et al: Immnune responses of rats to frozen bone allografts. J Bone Joint Surg 65A:239-246,1983.
9. Bruder SP, Kraus KH, Goldberg VM, Kadiyala S: The effect of implants loaded with autologous mesenchymal stem cells on the healing of canine segmental bone defects. J Bone Joint Surg 80A: 985-996, 1998.
10. Bucholz RW: Nonallograft osteoconductive bone graft substitutes. Clin Orthop 395:44-52, 2002.
11. Bucholz RW, Carlton A, Holmes R: Interporous hydroxyapatite as a bone graft substitute in tibial plateau fractures. Clin Orthop 240:53-62, 1989.
12. Buma P, Lamerigts N, Schreurs BW, et al: Impacted graft incorporation after cemented acetabular revision: Histological evaluation in 8 patients. Acta Orthop Scand 67:536-540, 1996.
13. Burwell RG: Studies in the transplantation of bone: V: The capacity of fresh and treated homografts of bone to evoke transplantation immunity. J Bone Joint Surg 45B:386-401, 1963.
14. Conn RA, Peterson LFA, Stauffer RN, Ilstrup D: Management of acetabular deficiency: Long-term results of bone grafting the acetabulum in total hip arthroplasty. Orthop Trans 9:451-452, 1985.
15. Connolly JF: Injectable bone marrow preparations to stimulate osteogenic repair. Clin Orthop 313:8-18, 1995.
16. Constantz BR, Ison IC, Fulmer MT, et al: Skeletal repair by in situ formation of the mineral phase of bone. Science 267:1796-1799, 1995.
17. Cook SD, Baffes GC, Wolfe MW, et al: The effect of recombinant human osteogenic protein-1 on healing of large segmental bone defects. J Bone Joint Surg 76A:827-838, 1994.
18. Cook SD, Baffes GC, Wolfe MW, Sampath TK, Rueger DC: Recombinant human bone morphogenetic protein-7 induces healing in a canine long-bone segmental defect model. Clin Orthop 301:302-312, 1994.
19. Cook SD, Barrack RL, Santman M, et al: The Otto Aufranc Award: Strut allograft healing to the femur with recombinant human osteogenic protein-1. Clin Orthop 381:47-57, 2000.
20. Cook SD, Barrack RL, Shimmin A, Morgan D, Carvajal JP: The use of osteogenic protein-1 in reconstructive surgery of the hip. J Arthroplasty 16(Suppl 1):88-94, 2001.
21. Cook SD, Wolfe MW, Salkeld SL, Rueger DC: Effect of recombinant human osteogenic protein-1 on healing of segmental defects in non-human primates. J Bone Joint Surg 77A:734-750, 1995.
22. D'Antonio JA, Capello WN, Borden LS, et al: Classification and management of acetabular abnormalities in total hip arthroplasty. Clin Orthop 243:126-137, 1989.
23. Dell PC, Burchardt H, Glowczewskie Jr FP: A roentgenographic, biomechanical, and histological evaluation of vascularized and non-vascularized segmental fibular canine autografts. J Bone Joint Surg 67A:105-112, 1985.
24. Dorr LD, Wan Z: Ten years of experience with porous acetabular components for failed cemented total hip arthroplasty. Clin Orthop 319:191-200, 1995.
25. Einhorn TA, Lane JM, Burstein AH, Kopman CR, Vigorita VJ: The healing of segmental bone defects induced by demineralized bone matrix: A radiographic and biomechanical study. J Bone Joint Surg 66A:274-279, 1984.
26. Emerson RH, Head WC, Berklacich FM, Malinin TI: Noncemented acetabular revision arthroplasty using allograft bone. Clin Orthop 249:30-43, 1989.
27. Finkemeier CGL: Bone-grafting and bone-graft substitutes. J Bone Joint Surg 84A:454-464, 2002.
28. Frenkel SR, Moskovich R, Spivak J, Zhang ZH, Prewett AB: Demineralized bone matrix: Enhancement of spinal fusion. Spine 18:1634-1639, 1993.
29. Friedlaender GE: The antigenicity of preserved allografts. Transplant Proc 8(Suppl 1):195-200, 1976.
30. Garbuz D, Morsi E, Mohamed N, Gross AE: Classification and reconstruction in revision acetabular arthroplasty with bone stock deficiency. Clin Orthop 323:98-107, 1996.
31. Gazdag AR, Lane JM, Glaser D, Forster RA: Alternatives to autogenous bone graft: Efficacy and indications. J Am Acad Orthop Surg 3:1-8, 1995.
32. Gie GA, Linder L, Ling RS, et al: Impacted cancellous allografts and cement for revision total hip arthroplasty. J Bone Joint Surg 75B: 14-21, 1993.
33. Goldberg VM: Selection of bone grafts for revision total hip arthroplasty. Clin Orthop 381:68-76, 2000.
34. Goldberg VM, Stevenson S: Natural history of autografts and allografts. Clin Orthop 225:7-16, 1987.
35. Goodman SB, Bauer TW, Carter D, et al: Norian SRS cement augmentation in hip fracture treatment: Laboratory and initial clinical results. Clin Orthop 348:42-50, 1998.
36. Gray JC, Elves MW: Early osteogenesis in compact bone isografts: A quantitative study of contributions of the different graft cells. Calcif Tissue Int 29:225-237, 1979.
37. Greenwald AS, Boden SD, Goldberg VM, et al: Bonegraft substitutes: Facts, fictions, and applications. J Bone Joint Surg 83A(Suppl 2):98-103, 2001.
38. Haddad FS, Masri BA, Garbuz DS, Duncan CP: Femoral bone loss in total hip arthroplasty: Classification and preoperative planning. Instr Course Lect 49:83-96, 2000.
39. Heekin RD, Engh CA, Vinh T: Morselized allograft in acetabular reconstruction: A postmortem retrieval analysis. Clin Orthop 319:184-190, 1995.
40. Johnson EE, Urist MR, Finerman GA: Resistant non-unions and partial or complete segmental defects of long bones: Treatment with implants of a composite of human bone morphogenetic protein (BMP) and autolyzed, antigen-extracted, allogeneic (AAA) bone. Clin Orthop 277:229-237, 1992.
41. Jupiter JB, Winters S, Sigman S, et al: Repair of five distal radius fractures with an investigational cancellous bone cement: A preliminary report. J Orthop Trauma 11:110-116, 1997.
42. Kadiyala S, Jaiswal N, Bruder SP: Culture expanded bone-marrow derived stem cells can regenerate a critical sized segmental bone defect. Tissue Eng 3:173-185, 1997.
43. Kakiuchi M, Hosoya T, Takaoka K, Amitani K, Ono K: Human bone matrix gelatin as a clinical alloimplant: A retrospective review of 160 cases. Int Orthop 9:181-188, 1985.
44. Kondo K, Nagaya I: Bone incorporation of frozen femoral head allograft in revision total hip replacement. Nippon Seikeigeka Gakkai Zasshi 67:408-416, 1993.
45. Kopylov P, Runnqvist K, Jonsson K, Aspenberg P: Norian SRS versus external fixation in redisplaced distal radial fractures: A randomized study in 40 patients. Acta Orthop Scand 70:1-5, 1999.
46. Lee GH, Khoury JG, Bell JE, Buckwalter JA: Adverse reactions to Osteoset bone graft substitute: The incidence in a consecutive series. Iowa Orthop J 22:35-38, 2002.
47. Lee JY, Musgrave D, Pelinkovic D, et al: Effect of bone morphogenetic protein-2-expressing muscle-derived cells on healing of critical-sized bone defects in mice. J Bone Joint Surg 83A: 1032-1039, 2001.
48. Leopold SS, Jacobs JJ, Rosenberg AG: Cancellous allograft in revision total hip arthroplasty: A clinical review. Clin Orthop 371:86-97, 2000.
49. Leopold SS, Rosenberg AG, Bhatt RD, et al: Cementless acetabular revision: Evaluation at an average of 10.5 years. Clin Orthop 369:179-187, 1999.
50. Lieberman JR, Daluiski A, Stevenson S, et al: The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats. J Bone Joint Surg 81A:905-917, 1999.
51. Lieberman JR, Le LQ, Wu L, et al: Regional gene therapy with a BMP-2-producing murine stromal cell line induces heterotopic and orthotopic bone formation in rodents. J Orthop Res 16:330-339, 1998.
52. Lieberman JR, Stevenson S: Bone Grafts. In Pellicci PM, Tria AJ, Garvin K (eds). Orthopaedic Knowledge Update: Hip and Knee Reconstruction 2. Rosemont, IL, Amefican Academy or Orthopaedic Surgeons 35-41,2000.
53. Ling RS, Timperley AJ, Linder L: Histology of cancellous impaction grafting in the femur: A case report. J Bone Joint Surg 75B:693-696, 1993.
54. Looney RJ, Boyd A, Totterman S, et al: Volumetric computerized tomography as a measurement of periprosthetic acetabular osteolysis and its correlation with wear. Arthritis Res 4:59-63, 2002.
55. Lowery GL, Kulkami S, Pennisi AE: Use of autologous growth factors in lumbar spinal fusion. Bone 25(Suppl 2):47-50, 1999.
56. Martin GJ Jr, Boden SD, Marone MA, Marone MA, Moskovitz PA: Posterolateral intertransverse process spinal arthrodesis with rhBMP-2 in a nonhuman primate: important lessons learned regarding dose, carrier, and safety. J Spinal Disord 12:179-186, 1999.
57. Nelissen RG, Bauer TW, Weidenhielm LR, LeGolvan DP, Mikhail WE: Revision hip arthroplasty with the use of cement and impaction grafting: Histological analysis of four cases. J Bone Joint Surg 77A:412-422, 1995.
58. Nivbrant B, Kärrholm J: Migration and wear of hydroxyapatite-coated press-fit cups in revision hip arthroplasty: A radiostereometric study. J Arthroplasty 12:904-912, 1997.
59. Oakes DA, Lee CC, Lieberman JR: An evaluation of demineralized bone matrices in a rat femoral defect model. Clin Orthop 413:281-290, 2003.
60. Padgett DE, Kull L, Rosenberg A, Sumner DR, Galante JO: Revision of the acetabular component without cement after total hip arthroplasty: Three to six-year follow-up. J Bone Joint Surg 75A:663-673, 1993.
61. Paprosky WG, Bumett RS: Assessment and classification of bone stock deficiency in revision total hip arthroplasty. Am J Orthop 8:459-464, 2002.
62. Paprosky WG, Perona PG, Lawrence JM: Acetabular defect classification and surgical reconstruction in revision arthroplasty: A 6-year follow-up evaluation. J Arthroplasty 9:33-44, 1994.
63. Pluhar GE, Manley PA, Heiner JP, et al: The effect of recombinant human bone morphogenetic protein-2 on femoral reconstruction with an intercalary allograft in a dog model. J Orthop Res 19:308-317, 2001.
64. Salkeld SL, Patron LP, Barrack RL, Cook SD: The effect of osteogenic protein-1 on the healing of segmental bone defects treated with autograft or allograft bone. J Bone Joint Surg 83A:803-816, 2001.
65. Sandhu HS, Kanim LE, Kabo JM, et al: Effective doses of recombinant human bone morphogenetic protein-2 in experimental spinal fusion. Spine 21:2115-2122, 1996.
66. Sandhu HS, Kanim LE, Toth JM, et al: Experimental spinal fusion with recombinant human bone morphogenetic protein-2 without decortication of osseous elements. Spine 22:1171-1180, 1997.
67. Schwartz Z, Mellonig JT, Carnes DL Jr, et al: Ability of commercial demineralized freeze-dried bone allograft to induce new bone formation. J Periodontol 67:918-926, 1996.
68. Shih CH, Chen CH, Tsai MF, Tzen KY: Incorporation of allograft for acetabular reconstruction: Single photon emission CT in 21 hip arthroplasties followed for 2.5-5 years. Acta Orthop Scand 65:589-594, 1994.
69. Siebrecht MA, De Rooij PP, Arm DM, Olsson ML, Aspenberg P: Platelet concentrate increases bone ingrowth into porous hydroxyapatite. Orthopedics 25:169-172, 2002.
70. Stevenson S, Horowitz M: The response to bone allografts. J Bone Joint Surg 74A:939-950, 1992.
71. Summers BN, Eisenstein SM: Donor site pain from the ilium: A complication of lumbar spine fusion. J Bone Joint Surg 71B:677-680, 1989.
72. Tiedeman JJ, Garvin KL, Kile TA, Connolly JF: The role of a composite, demineralized bone matrix and bone marrow in the treatment of osseous defects. Orthopedics 18:1153-1158, 1995.
73. Urist MR: Bone: Formation by autoinduction. Science 150:893-899, 1965.
74. Urist MR: Bone Transplants and Implants. In Urist MR (ed). Fundamental and Clinical Bone Physiology. Philadelphia, JB Lippincott 331-368,1980.
75. Urist MR, Silverman BF, Buring K, Dubuc FL, Rosenberg JM: The bone induction principle. Clin Orthop 53:243-283, 1967.
76. Valentin-Opran A, Wozney J, Csimma C, Lilly L, Riedel GE: Clinical evaluation of recombinant human bone morphogenetic protein-2. Clin Orthop 395:110-120, 2002.
77. van der Donk S, Buma P, Slooff TJ, Gardeniers JW, Schreurs BW: Incorporation of morselized bone grafts: A study of 24 acetabular biopsy specimens. Clin Orthop 396:131-141, 2002.
78. Viggeswarapu M, Boden SD, Liu Y, et al: Adenoviral delivery of LIM mineralization protein-1 induces new-bone formation in vitro and in vivo. J Bone Joint Surg 83A:364-376, 2001.
79. Wang J, Glimcher MJ: Characterization of matrix-induced osteogenesis in rat calvarial bone defects: II Origins of bone-forming cells. Calcif Tissue Int 65:486-493, 1999.
80. Wang J, Glimcher MJ: Characterization of matrix-induced osteogenesis in rat calvarial bone defects: I. Differences in the cellular response to demineralized bone matrix implanted in calvarial defects and in subcutaneous sites. Calcif Tissue Int 65:156-165, 1999.
81. Wang JC, Kanim LA, Yoo S, et al: The effect of regional gene therapy with bone morphogenetic protein-2 producing bone marrow cells on spinal fusion in rats. J Bone Joint Surg 85A:905-911, 2003.
82. Whang PG, Lieberman JR: Clinical Issues in the Development of Cellular Systems for Use as Bone Graft Substitutes. In Laurencin C (ed). Bone Graft Substitutes: A Multidisciplinary Approach. West Conshohocken, PA, American Society for Testing and Materials 142-164, 2003.
83. www.aatb.org
84. www.fda.gov
85. Yasko AW, Lane JM, Fellinger EJ, et al: The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2): A radiographic, histological, and biomechanical study in rats. J Bone Joint Surg 74A:659-670, 1992.
86. Yoon ST, Boden SD: Osteoinductive molecules in orthopaedics: Basic science and preclinical studies. Clin Orthop 395:33-43, 2002.
87. Zabka AG, Pluhar GE, Edwards III RB, et al: Histomorphometric description of allograft bone remodeling and union in a canine segmental femoral defect model: A comparison of rhBMP-2, cancellous bone graft, and absorbable collagen sponge. J Orthop Res 19:318-327, 2001.